Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastric and intestinal mucosal surfaces constitute the innermost lining of the gastrointestinal tract, acting as a vital barrier between the lumen and the systemic circulation (NIH: Gastrointestinal Mucosal Barrier, 2013). This multi-layered structure consists of an epithelial cell layer, a protective mucus coating, and the underlying lamina propria, which houses a significant portion of the body's immune system. Its primary biological roles include the selective absorption of nutrients, the secretion of digestive juices, and the prevention of pathogen entry (StatPearls: Physiology, Gastrointestinal, 2023). Pathological conditions such as peptic ulcers, gastritis, and inflammatory bowel disease involve the breakdown or inflammation of these surfaces. Pharmacological strategies often focus on enhancing mucosal defense mechanisms or reducing aggressive factors to promote healing and maintain the integrity of the gastrointestinal barrier (PubChem: Sucralfate, 2024). While not a single molecular target, these surfaces are the site of action for various cytoprotective and anti-inflammatory agents.
Drugs interacting with these surfaces typically function by providing a physical protective coating, stimulating the production of protective mucus and bicarbonate, or reducing the secretion of damaging agents like gastric acid to allow for tissue repair (StatPearls: Physiology, Gastrointestinal, 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric and intestinal mucosal surfaces (GI mucosa).